SCM
BHVN icon

Soleus Capital Management’s Biohaven BHVN Stock Holding History

Soleus Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-113,800
Closed -$2.96M – 80
2023
Q3 		$2.96M Buy
+113,800
New +$2.37M 0.27% 63

Other funds holding BHVN

Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Soleus Capital Management's BHVN Position: Q4 2023 in Review

Soleus Capital Management sold out of Biohaven (BHVN) in Q4 2023, closing a stake of 113,800 shares — an estimated $2.96M sold.

Soleus Capital Management first reported a position in BHVN in Q3 2023 and held it in 1 quarter. The position peaked at $2.96M in Q3 2023. 218 funds tracked by Wall St. Rank hold BHVN as of Q4 2023.

  • Soleus Capital Management reported no remaining Biohaven position as of Q4 2023 after selling out during the quarter.
  • Soleus Capital Management sold 113,800 Biohaven shares in Q4 2023, an estimated $2.96M.
  • Soleus Capital Management first reported a position in Biohaven in Q3 2023 and held it in 1 quarter.
  • Soleus Capital Management's Biohaven position peaked at $2.96M in Q3 2023.
  • 218 funds tracked by Wall St. Rank held Biohaven as of Q4 2023.

Based on Soleus Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.